Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Benign lesions that mimic breast cancer

BGICC 2020

Published: 27 Jan 2020

Views: 507

Rating:

Save

Dr Hannah Chung - University of Texas, Houston, USA

Dr Hannah Chung speaks to ecancer at the BGICC 2020 conference in Cairo, Egypt.

She explains how benign lesions may mimic breast cancer and how they can be distinguished from cancerous ones.

Related Videos

Baseline characteristics of patients with PSMA-PET–positive and –negative...

Prof Boris Hadaschik - University of Duisburg-Essen, Essen, Germany

Baseline characteristics of patients with PSMA-PET–positive and –negative disease with high-risk BCR after radical RP ( Prof Boris Hadaschik - University of Duisburg-Essen, Essen, Germany )

A biomarker led approach to bladder cancer

Prof Andrea Necchi, Dr Guillermo De Velasco, Prof Arlene Siefker-Radtke and Dr...

A biomarker led approach to bladder cancer ( Prof Andrea Necchi, Dr Guillermo De Velasco, Prof Arlene Siefker-Radtke and Dr Yohann Loriot )

Early-stage breast cancer detection in breast milk

Dr Cristina Saura - Vall d’Hebron University Hospital, Barcelona, Spain

Early-stage breast cancer detection in breast milk ( Dr Cristina Saura - Vall d’Hebron University Hospital, Barcelona, Spain )

A reproducibility study in pulmonary adenocarcinomas supports a revised...

Dr Erik Thunnissen - VU University Medical Center, Amsterdam, The Netherlands

A reproducibility study in pulmonary adenocarcinomas supports a revised classification ( Dr Erik Thunnissen - VU University Medical Center, Amsterdam, The Netherlands )

The Southeast Asian Breast Cancer Symposium; background, aims and successes

Carolyn Taylor - Executive Director, Global Focus on Cancer

The Southeast Asian Breast Cancer Symposium; background, aims and successes ( Carolyn Taylor - Executive Director, Global Focus on Cancer )

Advancing breast cancer treatment in Uganda by improving molecular testing

Dr Jackson Orem - Uganda Cancer Institute, Kampala, Uganda

Advancing breast cancer treatment in Uganda by improving molecular testing ( Dr Jackson Orem - Uganda Cancer Institute, Kampala, Uganda )

Somatic mutation profile of breast cancer in Uganda

Dr Manoj Menon - Fred Hutchinson Cancer Center, Seattle, USA

Why tumour markers are not recommended as screening tests

Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines

Why tumour markers are not recommended as screening tests ( Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines )

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+...

Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )

More from ecancer